Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

What effect does androgen suppression therapy have on frequency and timing of fatal myocardial infarctions?

Nature Clinical Practice Oncology volume 5, pages 74–75 (2008)Cite this article

boxed-textD'Amico AV et al. (2007) Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol 25: 2420–2425

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bolla M et al. (2002) Long term results with immediate androgen suppression therapy and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomized trial. Lancet 360: 103–108

    Article  CAS  Google Scholar 

  2. Holzbeierlein JM et al. (2004) Complications of androgen deprivation therapy: prevention and treatment. Oncology 18: 303–309

    PubMed  Google Scholar 

  3. Byar DP and Corle DK (1988) Hormone therapy for prostate cancer: results of the Veterans Administration Cooperative Urological Research Group studies. NCI Monogr 7: 165–170

    Google Scholar 

  4. Abrahamsson PA et al. (2005) Risks and benefits of hormonal manipulation as monotherapy or adjuvant treatment in localised prostate cancer. Eur Urol 48: 900–905

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Urology, University of Kansas Hospital, 3901 Rainbow Boulevarde, Mail Stop 3016, Kansas City, KS 66160, USA jholzbeierlein@kumc.edu

Authors and Affiliations

  1. JM Holzbeierlein is an Associate Professor of Urology at the University of Kansas Hospital, Kansas City, KS, USA.,

    Jeffrey M Holzbeierlein

Authors
  1. Jeffrey M Holzbeierlein
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holzbeierlein, J. What effect does androgen suppression therapy have on frequency and timing of fatal myocardial infarctions?. Nat Rev Clin Oncol 5, 74–75 (2008). https://doi.org/10.1038/ncponc1003

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc1003

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing